ID,Substitution,MutPred2 score,Molecular mechanisms with Pr >= 0.01 and P < 0.05,Motif information,Remarks
humanN0.HOG0006492,V18S,0.778,Gain of Intrinsic_disorder (Pr = 0.48 | P = 2.5e-03); Altered Cytoplasmic_loop (Pr = 0.28 | P = 4.3e-04),Altered Motifs (ELME000064:CK2 phosphorylation site; ELME000085:Glycosaminoglycan attachment site; ELME000147:Site phosphorylated by the Polo-like kinase.; PS00006:Casein kinase II phosphorylation site),Predicted conservation scores
humanN0.HOG0011333,G203N,0.709,Altered PPI_residue (Pr = 0.35 | P = 3.7e-03); Altered Cytoplasmic_loop (Pr = 0.30 | P = 1.4e-04); Gain of ADP-ribosylation at R205 (Pr = 0.22 | P = 0.02),Altered Motifs (ELME000231:An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner; PS00008:N-myristoylation site),Predicted conservation scores
humanN0.HOG0011799,T20V,0.643,Gain of Catalytic_site at N24 (Pr = 0.08 | P = 0.05),Altered Motifs (ELME000124:FxDxF motif responsible for the binding of accessory endocytic proteins to the appendage of the alpha-subunit of adaptor protein complex AP-2; ELME000328:Fxxx[WF] motifs are present in Pex19 and S. cerevisiae Pex5 cytosolic receptors that bind to peroxisomal membrane docking member - Pex14; ELME000336:NEK2 phosphorylation motif with preferred Phe - Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.),-
humanN0.HOG0009594,T417V,0.616,Loss of Relative_solvent_accessibility (Pr = 0.27 | P = 0.02); Loss of Acetylation at K413 (Pr = 0.21 | P = 0.03); Loss of Ubiquitylation at K413 (Pr = 0.17 | P = 0.03),Altered Motifs (ELME000045:The nuclear receptor box motif (LXXLL) confers binding to nuclear receptors.; ELME000052:Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.; ELME000106:Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.; ELME000146:Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X); ELME000333:Motif that mediates binding to SUMO proteins non-covalently.),-
humanN0.HOG0009352,H206C,0.553,Gain of Pyrrolidone_carboxylic_acid at Q208 (Pr = 0.06 | P = 0.03),Altered Motifs (None),-
humanN0.HOG0006841,A539L,0.502,Gain of Strand (Pr = 0.27 | P = 0.02),Altered Motifs (ELME000147:Site phosphorylated by the Polo-like kinase.; ELME000335:Inverted version of LIG_SUMO_SBM_1 that mediates binding to SUMO proteins non-covalently.),-
humanN0.HOG0005491,V154M,0.498,Altered MoRF (Pr = 0.35 | P = 0.01); Gain of Intrinsic_disorder (Pr = 0.33 | P = 0.03),Altered Motifs (ELME000063:CK1 phosphorylation site; ELME000147:Site phosphorylated by the Polo-like kinase.),-
humanN0.HOG0005491,S211L,0.484,Loss of Intrinsic_disorder (Pr = 0.41 | P = 0.02); Loss of Strand (Pr = 0.28 | P = 8.2e-03),Altered Motifs (ELME000065:Phosphorylase kinase phosphorylation site; ELME000146:Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X); ELME000149:Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes; ELME000173:Consensus derived from reported natural interactors which do not  match the Mode 1 and Mode 2 ligands.; ELME000333:Motif that mediates binding to SUMO proteins non-covalently.),-
humanN0.HOG0007831,S202R,0.461,Loss of Zinc_binding at H197 (Pr = 0.28 | P = 0.02); Altered PPI_hotspot (Pr = 0.27 | P = 8.2e-03); Loss of Nickel_binding at H197 (Pr = 0.26 | P = 8.4e-03); Loss of Strand (Pr = 0.26 | P = 0.05); Loss of Allosteric_site at Y205 (Pr = 0.23 | P = 0.03); Altered Cytoplasmic_loop (Pr = 0.21 | P = 4.0e-03),Altered Motifs (ELME000085:Glycosaminoglycan attachment site; ELME000336:NEK2 phosphorylation motif with preferred Phe - Leu or Met in the -3 position to compensate for less favorable residues in the +1 and +2 position.),-
humanN0.HOG0009451,E29R,0.447,Altered Cytoplasmic_loop (Pr = 0.38 | P = 1.5e-05); Loss of Relative_solvent_accessibility (Pr = 0.31 | P = 6.9e-03); Altered PPI_residue (Pr = 0.29 | P = 0.03); Altered Coiled_coil (Pr = 0.17 | P = 0.02); Loss of Potassium_binding at E29 (Pr = 0.11 | P = 0.04); Loss of Sulfation at Y32 (Pr = 0.02 | P = 0.03),Altered Motifs (None),-
humanN0.HOG0013726,Q204R,0.408,Altered Cytoplasmic_loop (Pr = 0.31 | P = 9.7e-05); Loss of Loop (Pr = 0.27 | P = 0.05); Gain of SUMOylation at K209 (Pr = 0.21 | P = 0.03); Gain of Copper_binding at C201 (Pr = 0.05 | P = 0.04); Loss of Pyrrolidone_carboxylic_acid at Q204 (Pr = 0.05 | P = 0.04),Altered Motifs (None),Predicted conservation scores
humanN0.HOG0010383,D37K,0.406,Altered Coiled_coil (Pr = 0.61 | P = 3.0e-03); Loss of Zinc_binding at D37 (Pr = 0.30 | P = 0.01),Altered Motifs (ELME000149:Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes; ELME000335:Inverted version of LIG_SUMO_SBM_1 that mediates binding to SUMO proteins non-covalently.),-
humanN0.HOG0014055,S359P,0.396,,Altered Motifs (ELME000005:This is the motif recognized by class I SH3 domains; ELME000052:Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.; ELME000057:Proline-rich motif binding to signal transduction class I EVH1 domains.; ELME000155:This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity; ELME000249:TRF1 and TRF2 both bind to another shelterin protein- TIN2. The TRF1-TIN2 interaction was mediated by a short motif in the N-Ter of TIN2. TIN2 connects TRF1 to TRF2 - this link contributes to the stabilization of TRF2 on telomeres.),-
humanN0.HOG0011904,A18N,0.38,Altered Signal_helix (Pr = 0.32 | P = 1.9e-04); Altered C-terminal_signal (Pr = 0.30 | P = 6.3e-05),Altered Motifs (ELME000045:The nuclear receptor box motif (LXXLL) confers binding to nuclear receptors.),-
humanN0.HOG0013362,I122V,0.359,Altered MoRF (Pr = 0.28 | P = 0.04); Loss of Strand (Pr = 0.27 | P = 0.02); Altered Cytoplasmic_loop (Pr = 0.26 | P = 1.0e-03); Altered Stability (Pr = 0.15 | P = 0.02); Loss of N-linked_glycosylation at N126 (Pr = 0.06 | P = 0.02),Altered Motifs (ELME000053:GSK3 phosphorylation recognition site; ELME000237:Calcineurin substrate docking site - leads to the effective dephosphorylation of serine/threonine phosphorylation sites.; ELME000239:The USP7 NTD domain binding motif variant based on the MDM2 and P53 interactions.),Predicted conservation scores
humanN0.HOG0006548,M158T,0.346,Altered PPI_residue (Pr = 0.29 | P = 0.03); Gain of Sodium_binding at D157 (Pr = 0.29 | P = 3.9e-03); Gain of Allosteric_site at P162 (Pr = 0.21 | P = 0.03); Altered Stability (Pr = 0.19 | P = 0.01); Altered Cytoplasmic_loop (Pr = 0.17 | P = 0.01); Gain of Manganese_binding at D157 (Pr = 0.16 | P = 0.03); Loss of Potassium_binding at I163 (Pr = 0.14 | P = 0.02); Loss of Copper_binding at D157 (Pr = 0.05 | P = 0.03); Gain of Sulfation at Y155 (Pr = 0.02 | P = 0.02),Altered Motifs (ELME000051:Longer mode 2 interacting phospho-motif for 14-3-3 proteins with key conservation RxxxS#p.; ELME000052:Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.; ELME000120:Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex; ELME000147:Site phosphorylated by the Polo-like kinase.; ELME000335:Inverted version of LIG_SUMO_SBM_1 that mediates binding to SUMO proteins non-covalently.),-
humanN0.HOG0007883,H509C,0.29,Loss of Nickel_binding at H509 (Pr = 0.50 | P = 8.2e-04); Loss of Zinc_binding at H509 (Pr = 0.47 | P = 4.6e-03); Loss of Intrinsic_disorder (Pr = 0.37 | P = 0.04); Altered MoRF (Pr = 0.33 | P = 0.01); Altered DNA_binding (Pr = 0.28 | P = 4.9e-03); Loss of Allosteric_site at H509 (Pr = 0.25 | P = 0.02); Gain of ADP-ribosylation at R504 (Pr = 0.19 | P = 0.05); Loss of SUMOylation at K513 (Pr = 0.18 | P = 0.05); Loss of Manganese_binding at E508 (Pr = 0.16 | P = 0.04); Loss of Potassium_binding at I514 (Pr = 0.13 | P = 0.03),Altered Motifs (ELME000053:GSK3 phosphorylation recognition site; ELME000062:Secondary preference for PKA-type AGC kinase phosphorylation.),Predicted conservation scores
humanN0.HOG0005894,A167M,0.284,Loss of Phosphorylation at T169 (Pr = 0.30 | P = 0.02); Gain of SUMOylation at K164 (Pr = 0.19 | P = 0.04),Altered Motifs (ELME000053:GSK3 phosphorylation recognition site; ELME000063:CK1 phosphorylation site; ELME000085:Glycosaminoglycan attachment site; ELME000136:The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.; ELME000153:Substrate motif for phosphorylation by CDK; ELME000159:Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.; ELME000254:SxIP motifs bind to EBH domains.),-
humanN0.HOG0007478,T24I,0.268,Gain of Strand (Pr = 0.27 | P = 0.03); Loss of ADP-ribosylation at R29 (Pr = 0.22 | P = 0.03),Altered Motifs (ELME000052:Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.; ELME000053:GSK3 phosphorylation recognition site; ELME000063:CK1 phosphorylation site; ELME000136:The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.; ELME000159:Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.),-
humanN0.HOG0009522,M1L,0.267,Altered N-terminal_signal (Pr = 0.17 | P = 9.9e-04); Altered Signal_helix (Pr = 0.02 | P = 6.6e-03),Altered Motifs (ELME000060:Generic motif for N-Myristoylation site.; ELME000355:N-terminal motif that initiates protein degradation by binding to the N-box of N-recognins. This N-degron variant comprises N-terminal a bulky hydrophobic residue as destabilizing residue.),-
humanN0.HOG0013383,T925M,0.249,Gain of Helix (Pr = 0.27 | P = 0.04),Altered Motifs (PS00008:N-myristoylation site),-
humanN0.HOG0003771,I433V,0.246,Altered Transmembrane_region (Pr = 0.04 | P = 6.1e-04),Altered Motifs (ELME000317:Motif binding to the dorsal surface of eIF4E.),-
humanN0.HOG0004037,I331L,0.205,Gain of Helix (Pr = 0.27 | P = 0.04),Altered Motifs (None),-
humanN0.HOG0010894,R186Q,0.202,Loss of Pyrrolidone_carboxylic_acid at Q184 (Pr = 0.04 | P = 0.05),Altered Motifs (ELME000005:This is the motif recognized by class I SH3 domains; ELME000155:This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity),-
humanN0.HOG0011389,L146A,0.186,,Altered Motifs (ELME000064:CK2 phosphorylation site; ELME000220:Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.; PS00006:Casein kinase II phosphorylation site),-
humanN0.HOG0005719,M235V,0.186,Loss of Helix (Pr = 0.27 | P = 0.04); Gain of Strand (Pr = 0.27 | P = 0.03); Altered Cytoplasmic_loop (Pr = 0.26 | P = 9.7e-04); Gain of Pyrrolidone_carboxylic_acid at Q239 (Pr = 0.12 | P = 6.8e-03); Loss of GPI-anchor_amidation at N240 (Pr = 0.03 | P = 0.01),Altered Motifs (ELME000064:CK2 phosphorylation site; ELME000117:Major TRAF2-binding consensus motif. Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmic tails.; ELME000220:Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.; PS00006:Casein kinase II phosphorylation site),-
humanN0.HOG0008545,S524I,0.183,Loss of Intrinsic_disorder (Pr = 0.43 | P = 0.02); Altered PPI_residue (Pr = 0.40 | P = 1.3e-03); Loss of Relative_solvent_accessibility (Pr = 0.38 | P = 1.2e-03); Loss of Sodium_binding at K519 (Pr = 0.35 | P = 1.3e-03); Altered Cytoplasmic_loop (Pr = 0.28 | P = 4.0e-04); Loss of Potassium_binding at K519 (Pr = 0.26 | P = 2.1e-03); Altered DNA_binding (Pr = 0.25 | P = 7.1e-03); Gain of Zinc_binding at D520 (Pr = 0.24 | P = 0.04); Loss of Allosteric_site at K519 (Pr = 0.20 | P = 0.05); Loss of Nickel_binding at D520 (Pr = 0.19 | P = 0.03); Gain of Methylation at K519 (Pr = 0.18 | P = 7.7e-03); Loss of Ubiquitylation at K519 (Pr = 0.16 | P = 0.03); Loss of O-linked_glycosylation at S522 (Pr = 0.14 | P = 0.04); Loss of Manganese_binding at D520 (Pr = 0.13 | P = 0.05),Altered Motifs (ELME000052:Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.; ELME000063:CK1 phosphorylation site; ELME000085:Glycosaminoglycan attachment site; ELME000147:Site phosphorylated by the Polo-like kinase.; ELME000233:MAPK interacting molecules (e.g. MAPKKs - substrates - phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.),-
humanN0.HOG0012720,T774V,0.179,,Altered Motifs (ELME000053:GSK3 phosphorylation recognition site; ELME000202:(ST)Q motif which is phosphorylated by PIKK family members.; ELME000313:The WH2 motif is of variable length (16-19 amino acids) binding to the hydrophobic cleft formed by actin's subdomains 1 and 3. At the N-terminus it forms an alpha-helix followed by a flexible loop stabilised upon actin binding.),Predicted conservation scores
humanN0.HOG0012045,I349L,0.164,Loss of Strand (Pr = 0.26 | P = 0.03); Gain of Manganese_binding at E352 (Pr = 0.18 | P = 0.03),Altered Motifs (ELME000335:Inverted version of LIG_SUMO_SBM_1 that mediates binding to SUMO proteins non-covalently.),-
humanN0.HOG0009964,R1027H,0.161,Loss of Phosphorylation at S1023 (Pr = 0.28 | P = 0.02),Altered Motifs (ELME000100:NEC1/NEC2 cleavage site (Lys-Arg-|-Xaa); ELME000108:Yeast kexin 2 cleavage site (Lys-Arg-|-Xaa or Arg-Arg-|-Xaa)),Predicted conservation scores
humanN0.HOG0007498,V342L,0.157,Gain of Helix (Pr = 0.27 | P = 0.03); Altered Cytoplasmic_loop (Pr = 0.17 | P = 9.6e-03); Altered Signal_helix (Pr = 0.03 | P = 5.6e-03),Altered Motifs (None),-
humanN0.HOG0014933,H61C,0.156,Loss of Proteolytic_cleavage at D60 (Pr = 0.12 | P = 0.03),Altered Motifs (ELME000052:Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.),-
humanN0.HOG0014825,R116K,0.152,Altered Coiled_coil (Pr = 0.37 | P = 7.8e-03); Gain of B-factor (Pr = 0.26 | P = 0.02),Altered Motifs (ELME000008:Main preference for PKA-type AGC kinase phosphorylation.; ELME000012:The di-Arg ER retention motif is defined by two consecutive arginine residues (RR) or with a single residue insertion (RXR). The motif is completed by an adjacent hydrophobic/arginine residue which may be on either side of the Arg pair.; ELME000062:Secondary preference for PKA-type AGC kinase phosphorylation.; ELME000064:CK2 phosphorylation site; ELME000100:NEC1/NEC2 cleavage site (Lys-Arg-|-Xaa); ELME000108:Yeast kexin 2 cleavage site (Lys-Arg-|-Xaa or Arg-Arg-|-Xaa); PS00004:cAMP- and cGMP-dependent protein kinase phosphorylation site),Predicted conservation scores
humanN0.HOG0012010,N827G,0.146,Gain of Loop (Pr = 0.27 | P = 0.03),Altered Motifs (PS00008:N-myristoylation site),-
humanN0.HOG0013327,P619S,0.125,Loss of O-linked_glycosylation at T620 (Pr = 0.13 | P = 0.04); Loss of Pyrrolidone_carboxylic_acid at Q624 (Pr = 0.07 | P = 0.02),Altered Motifs (ELME000053:GSK3 phosphorylation recognition site; ELME000145:PxLxP motif is recognized by a subset of MYND domain containing proteins.; ELME000149:Sorting and internalisation signal found in the cytoplasmic juxta-membrane region of type I transmembrane proteins. Targets them from the Trans Golgi Network to the lysosomal-endosomal-melanosomal compartments. Interacts with adaptor protein (AP) complexes; ELME000155:This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity; ELME000239:The USP7 NTD domain binding motif variant based on the MDM2 and P53 interactions.),Predicted conservation scores
humanN0.HOG0012472,H530C,0.124,Loss of Intrinsic_disorder (Pr = 0.39 | P = 0.03),Altered Motifs (None),-
humanN0.HOG0011257,A100M,0.111,Altered Cytoplasmic_loop (Pr = 0.32 | P = 7.8e-05); Gain of Helix (Pr = 0.30 | P = 8.3e-03); Altered C-terminal_signal (Pr = 0.21 | P = 2.4e-04); Altered Signal_helix (Pr = 0.10 | P = 2.5e-03); Altered Signal_cleavage (Pr = 0.01 | P = 5.5e-04),Altered Motifs (ELME000052:Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.; ELME000136:The Class IV WW domain interaction motif is recognised primarily by the Pin1 phosphorylation-dependent prolyl isomerase.; ELME000159:Proline-Directed Kinase (e.g. MAPK) phosphorylation site in higher eukaryotes.; ELME000358:Phospho-dependent motif that mediates docking of CDK substrates and regulators to cyclin-CDK-bound Cks1.),-
humanN0.HOG0014649,S24T,0.11,Altered PPI_residue (Pr = 0.30 | P = 0.02); Loss of Relative_solvent_accessibility (Pr = 0.30 | P = 9.6e-03); Altered PPI_hotspot (Pr = 0.25 | P = 0.03); Altered Cytoplasmic_loop (Pr = 0.21 | P = 4.4e-03); Gain of Allosteric_site at Y23 (Pr = 0.20 | P = 0.04),Altered Motifs (ELME000053:GSK3 phosphorylation recognition site; ELME000084:GRB2-like Src Homology 2 (SH2) domains binding motif.; ELME000120:Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex; ELME000182:STAT5 Src Homology 2 (SH2) domain binding motif.; PS00008:N-myristoylation site),Predicted conservation scores
humanN0.HOG0008719,I102T,0.098,Altered Coiled_coil (Pr = 0.59 | P = 3.3e-03); Altered Stability (Pr = 0.48 | P = 1.8e-03); Loss of Relative_solvent_accessibility (Pr = 0.25 | P = 0.03); Loss of Acetylation at K99 (Pr = 0.25 | P = 0.01); Altered Calmodulin_binding (Pr = 0.19 | P = 0.04),Altered Motifs (ELME000008:Main preference for PKA-type AGC kinase phosphorylation.; ELME000062:Secondary preference for PKA-type AGC kinase phosphorylation.; ELME000106:Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.; ELME000146:Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X); ELME000220:Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 position.; ELME000231:An RxxL-based motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner; ELME000233:MAPK interacting molecules (e.g. MAPKKs - substrates - phosphatases) carry docking motif that help to regulate specific interaction in the MAPK cascade. The classic motif approximates (R/K)xxxx#x# where # is a hydrophobic residue.; ELME000271:Monopartite variant of the classical basically charged NLS. N-extended version.; ELME000333:Motif that mediates binding to SUMO proteins non-covalently.; ELME000335:Inverted version of LIG_SUMO_SBM_1 that mediates binding to SUMO proteins non-covalently.; PS00004:cAMP- and cGMP-dependent protein kinase phosphorylation site; PS00006:Casein kinase II phosphorylation site),-
humanN0.HOG0008719,T157M,0.08,Loss of Acetylation at K160 (Pr = 0.20 | P = 0.04),Altered Motifs (ELME000052:Phosphothreonine motif binding a subset of FHA domains that show a preference for a large aliphatic amino acid at the pT+3 position.; ELME000173:Consensus derived from reported natural interactors which do not  match the Mode 1 and Mode 2 ligands.; ELME000193:Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.),-
humanN0.HOG0008719,T417A,0.076,Loss of Allosteric_site at Y412 (Pr = 0.24 | P = 0.02); Loss of Nickel_binding at D413 (Pr = 0.21 | P = 0.02); Gain of Manganese_binding at D413 (Pr = 0.16 | P = 0.03); Altered Cytoplasmic_loop (Pr = 0.11 | P = 0.03); Loss of Catalytic_site at D413 (Pr = 0.09 | P = 0.04),Altered Motifs (ELME000335:Inverted version of LIG_SUMO_SBM_1 that mediates binding to SUMO proteins non-covalently.),-
humanN0.HOG0007433,S610G,0.075,,Altered Motifs (None),-
humanN0.HOG0006236,M185V,0.075,Altered Cytoplasmic_loop (Pr = 0.13 | P = 0.02),Altered Motifs (ELME000147:Site phosphorylated by the Polo-like kinase.; PS00006:Casein kinase II phosphorylation site),-
humanN0.HOG0013270,V525I,0.073,Loss of Loop (Pr = 0.27 | P = 0.03); Loss of ADP-ribosylation at R527 (Pr = 0.20 | P = 0.04); Altered Cytoplasmic_loop (Pr = 0.16 | P = 0.01),Altered Motifs (PS00008:N-myristoylation site),Predicted conservation scores
humanN0.HOG0012802,S222R,0.071,Loss of Strand (Pr = 0.27 | P = 0.02); Altered Cytoplasmic_loop (Pr = 0.26 | P = 8.8e-04); Loss of N-linked_glycosylation at N223 (Pr = 0.06 | P = 0.02),Altered Motifs (ELME000051:Longer mode 2 interacting phospho-motif for 14-3-3 proteins with key conservation RxxxS#p.; ELME000053:GSK3 phosphorylation recognition site; ELME000063:CK1 phosphorylation site; ELME000070:Generic motif for N-glycosylation. It was shown that Trp - Asp - and Glu are uncommon before the Ser/Thr position (PMID-8626433). Efficient glycosylation usually occurs when ~60 residues or more separate the glycosylation acceptor site from the C-terminus.; ELME000146:Subtilisin/kexin isozyme-1 (SKI1) cleavage site ([RK]-X-[hydrophobic]-[LTKF]-|-X); ELME000193:Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein.),-
humanN0.HOG0010903,D625P,0.062,Gain of B-factor (Pr = 0.26 | P = 0.02),Altered Motifs (ELME000155:This is the motif recognized by those SH3 domains with a non-canonical class I recognition specificity),Predicted conservation scores
humanN0.HOG0009004,S28A,0.058,Loss of Potassium_binding at D29 (Pr = 0.30 | P = 5.7e-04); Loss of Allosteric_site at W31 (Pr = 0.29 | P = 5.1e-03); Altered PPI_hotspot (Pr = 0.28 | P = 4.8e-03); Altered Cytoplasmic_loop (Pr = 0.27 | P = 5.8e-04); Loss of Sodium_binding at D29 (Pr = 0.22 | P = 0.03); Loss of Manganese_binding at S28 (Pr = 0.13 | P = 0.05); Loss of Catalytic_site at D29 (Pr = 0.11 | P = 0.04); Loss of Copper_binding at D29 (Pr = 0.08 | P = 0.01); Gain of Sulfation at Y32 (Pr = 0.03 | P = 0.02),Altered Motifs (ELME000239:The USP7 NTD domain binding motif variant based on the MDM2 and P53 interactions.),Predicted conservation scores
humanN0.HOG0012468,G49D,0.054,Altered Coiled_coil (Pr = 0.50 | P = 4.5e-03); Altered Cytoplasmic_loop (Pr = 0.29 | P = 2.9e-04); Gain of Relative_solvent_accessibility (Pr = 0.27 | P = 0.02); Gain of Sodium_binding at G49 (Pr = 0.26 | P = 0.01); Gain of Potassium_binding at G51 (Pr = 0.17 | P = 0.01); Gain of Ubiquitylation at K48 (Pr = 0.16 | P = 0.04),Altered Motifs (ELME000202:(ST)Q motif which is phosphorylated by PIKK family members.; PS00006:Casein kinase II phosphorylation site; PS00008:N-myristoylation site),-
humanN0.HOG0005457,R489Q,0.047,Altered MoRF (Pr = 0.28 | P = 0.04); Loss of Strand (Pr = 0.27 | P = 0.03); Loss of ADP-ribosylation at R489 (Pr = 0.26 | P = 8.5e-03); Gain of SUMOylation at K493 (Pr = 0.25 | P = 8.9e-03); Loss of Proteolytic_cleavage at D490 (Pr = 0.17 | P = 6.4e-03); Gain of O-linked_glycosylation at S491 (Pr = 0.17 | P = 0.02); Gain of Methylation at K493 (Pr = 0.11 | P = 0.03),Altered Motifs (ELME000062:Secondary preference for PKA-type AGC kinase phosphorylation.; ELME000134:Calmodulin binding helical peptide motif),Predicted conservation scores
humanN0.HOG0007338,E285G,0.046,Loss of Relative_solvent_accessibility (Pr = 0.32 | P = 4.9e-03); Loss of Manganese_binding at D289 (Pr = 0.29 | P = 5.1e-03); Loss of Nickel_binding at H282 (Pr = 0.28 | P = 5.7e-03); Loss of Loop (Pr = 0.27 | P = 0.04); Loss of Sodium_binding at D289 (Pr = 0.25 | P = 0.01); Altered Cytoplasmic_loop (Pr = 0.14 | P = 0.02); Gain of Copper_binding at H282 (Pr = 0.09 | P = 0.01),Altered Motifs (ELME000106:Substrate recognition site that interacts with cyclin and thereby increases phosphorylation by cyclin/cdk complexes. Predicted proteins should have a CDK phosphorylation site. Also used by cyclin/cdk inhibitors.; ELME000137:Protein phosphatase 1 catalytic subunit (PP1c) interacting motif binds targeting proteins that dock to the substrate for dephosphorylation. The motif defined is [RK]{0 -1}[VI][^P][FW].),-
